| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4208598 | Journal of Cystic Fibrosis | 2011 | 8 Pages |
Abstract
Based on these results the 400Â mg b.i.d. dose has been further studied in phase III trials.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Alejandro Teper, Anna Jaques, Brett Charlton,